Table 4.
Category | Adjusted OR (95% CI)a | P-value |
---|---|---|
Discharge Aspirin | 0.02b | |
eGFR effect in leading (>75%) hospitals | 1.06 (1.02, 1.11) | 0.003 |
eGFR effect in 50–75% hospitals | 1.05 (1.02, 1.08) | 0.002 |
eGFR effect in 25–50% hospitals | 1.06 (1.03, 1.09) | <0.001 |
eGFR effect in lagging (≤25%) hospitals | 1.00 (0.98, 1.02) | 0.9 |
Discharge clopidogrel | 0.02b | |
eGFR effect in leading (>75%) hospitals | 1.03 (1.01, 1.048) | 0.002 |
eGFR effect in 50–75% hospitals | 1.04 (1.03, 1.058) | <0.001 |
eGFR effect in 25–50% hospitals | 1.02 (1.00, 1.03) | 0.08 |
eGFR effect in lagging (≤25%) hospitals | 0.99 (0.97, 1.02) | 0.5 |
Discharge lipid-lowering agentc | 0.01b | |
eGFR effect in leading (>75%) hospitals | 1.050 (1.02, 1.08) | <0.001 |
eGFR effect in 50–75% hospitals | 1.051 (1.02, 1.08) | 0.001 |
eGFR effect in 25–50% hospitals | 1.04 (1.01, 1.07) | 0.007 |
eGFR effect in lagging (≤25%) hospitals | 1.00 (0.96, 1.03) | 0.8 |
Discharge ACE inhibitorsd | 0.05b | |
eGFR effect in leading (>75%) hospitals | 1.02 (0.99, 1.04) | 0.2 |
eGFR effect in 50–75% hospitals | 1.04 (1.01, 1.07) | 0.02 |
eGFR effect in 25–50% hospitals | 1.00 (0.98, 1.03) | 0.9 |
eGFR effect in lagging (≤25%) hospitals | 1.05 (1.03, 1.07) | <0.001 |
Abbreviations: eGFR, estimated glomerular filtration rate; ACE, angiotensin-converting enzyme.
Variables in the model – sex, white race, body mass index, age, heart rate, systolic blood pressure, family history of coronary artery disease, hypertension, diabetes, current/recent smoker, dyslipidemia, prior myocardial infarction, prior percutaneous coronary intervention, prior coronary artery bypass surgery, prior heart failure, prior stroke, ischemic electrocardiogram abnormalities, heart failure, positive cardiac markers; primary attending, insurance type, number of hospital beds, region, hospital capabilities, teaching/nonteaching hospital.
P-value for comparison of Odds Ratios between leading and lagging hospital rank groups
Among patients with history of dyslipidemia or low-density lipoprotein cholesterol levels >100 mg/dL
Among patients with history of, signs of, or in-hospital congestive heart failure, ejection fraction <40%, severe or moderate left ventricle dysfunction, diabetes mellitus, or hypertension